Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

27.65
-0.1300-0.47%
Post-market: 27.670.0195+0.07%19:59 EDT
Volume:28.81M
Turnover:793.87M
Market Cap:157.21B
PE:36.39
High:27.75
Open:27.69
Low:27.40
Close:27.78
52wk High:29.21
52wk Low:23.58
Shares:5.69B
Float Shares:5.64B
Volume Ratio:0.96
T/O Rate:0.51%
Dividend:1.72
Dividend Rate:6.22%
EPS(TTM):0.7599
EPS(LYR):1.36
ROE:5.01%
ROA:5.78%
PB:1.85
PE(LYR):20.27

Loading ...

Pfizer - Shipping of Xfg-Adapted Covid-19 Vaccine to Begin Soon

THOMSON REUTERS
·
Jul 30

Earning Preview: Pfizer this quarter’s revenue is expected to increase by 6.35%, and institutional views are cautious

Earnings Agent
·
Jul 29

Pfizer Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 29

Movement Alert|Pfizer Rises 3.08% in Regular Trading, Pharma Sector Broadly Lifted by GlaxoSmithKline Strong Q2 Earnings

Market Focus
·
Jul 28

Pfizer: Hold Rating Reiterated as Analyst Keeps $28 Price Target Unchanged Amid Balanced Pipeline Prospects and LOE Headwinds

TIPRANKS
·
Jul 28

Pfizer Ltd June-Quarter Net Profit 2.04 Billion Rupees

Reuters
·
Jul 28

Pfizer’s Bold Pipeline Bets Aim to Revive PFE

TIPRANKS
·
Jul 25

Pfizer’s PF-08057418 Clears Phase 1 Safety Milestone, Offering a Quiet Boost to Pipeline Confidence

TIPRANKS
·
Jul 25

How Investors May Respond To Pfizer (PFE) Prostate Cancer Combo Drug Label Expansion Push

Simply Wall St.
·
Jul 24

Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Healthcare Services (HCSG)

TIPRANKS
·
Jul 23

NYSE Most Active Issues

Dow Jones
·
Jul 23

Pfizer's Talzenna-xtandi Combo Gets FDA Priority Review for Earlier-stage Prostate Cancer

Dow Jones
·
Jul 23

Pfizer's Prostate Cancer Drug Combination Gets FDA Priority Review

Reuters
·
Jul 23

FDA Grants Priority Review for Pfizer’s Talzenna Plus Xtandi for the Treatment of Metastatic Prostate Cancer

THOMSON REUTERS
·
Jul 23

Pfizer - FDA Sets Pdufa Action Date for Talzenna Plus Xtandi in Q4 2026

THOMSON REUTERS
·
Jul 23

Pfizer (PFE) Faces New Patent Lawsuits Over Covid 19 Vaccine Technology

Simply Wall St.
·
Jul 23

Trump Announces Two-Year Zero Tariffs On Imported Generics From Aug. 1, 2026; Then 100% And 200% Hikes

MT Newswires Live
·
Jul 22

Moderately bullish activity in Pfizer with shares up 0.67%

TIPRANKS
·
Jul 22

NYSE Most Active Issues

Dow Jones
·
Jul 21

Cboe data shows mixed options sentiment in Pfizer with shares down 0.7%

TIPRANKS
·
Jul 20